This federal contract award, with an ID of SPE2DB24D2205|SPE2DB25FEBDC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,957,290 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $3,401.60 and an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FVZW6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,783.60 and a period of performance through January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,646.16, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 24, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
This federal contract award, with an ID of SPE2DB22D3010|SPE2DB25FP2AN, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567717274 ! VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,269.56. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The period of performance runs through March 28, 2025. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,346.26 and a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, SPE2DX15D1007|SPE2DX24F6T9Q, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,563,851,399 units of VYVANSE 30 MG CAPSULE 100S. The award, valued at $2,742.21, is a delivery order contract with a firm fixed price. The contract has no set-aside designation and will be completed by March 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This contract award, valued at $2,074.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4566606245 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,720.06, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has a period of performance through June 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,868.88, is for the delivery of 4567777500 units of the prescription drug VYVANSE 20 MG CAPSULE 100S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 2, 2025. The contract was awarded on April 1, 2025 and does not have a set-aside...